SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-072418
Filing Date
2017-12-08
Accepted
2017-12-08 09:02:26
Documents
7
Period of Report
2017-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-28200_18k.htm 8-K 39049
2 EX-4.1 a17-28200_1ex4d1.htm EX-4.1 110103
3 EX-5.1 a17-28200_1ex5d1.htm EX-5.1 12108
4 EX-10.1 a17-28200_1ex10d1.htm EX-10.1 261069
5 EX-10.2 a17-28200_1ex10d2.htm EX-10.2 63876
6 EX-99.1 a17-28200_1ex99d1.htm EX-99.1 10737
7 GRAPHIC g282001kl01i001.jpg GRAPHIC 3268
  Complete submission text file 0001104659-17-072418.txt   502869
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 171246151
SIC: 8071 Services-Medical Laboratories
Assistant Director 9